This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Agriculture Operations Outlook: Tariffs to Mar Organic Gains
by Rajani Lohia
The Zacks Agriculture - Operations industry should witness gains from wooing customers with organic solutions for crop production. Yet, tariff-related headwinds remain threats to top line.
Limoneira (LMNR) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 18.18% and -3.45%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Limoneira (LMNR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
US-China Trade Talks to Influence Agriculture Operations Outlook
by Rajani Lohia
The U.S. agriculture exports are widely impacted by the tariff war with China, the largest importer of U.S. soybeans. Nevertheless, initial U.S.-China trade talks bring hopes for the industry.
Archer Daniels' Cost Savings & Project Readiness Bode Well
by Zacks Equity Research
Archer Daniels (ADM) gains from its strategic initiatives such as cost savings, management of business portfolio and Project Readiness.
Limoneira (LMNR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -83.33% and -6.08%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 9.09% and -11.84%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Limoneira (LMNR) Q4 Earnings Expected to Decline
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agriculture-Operations Industry Rides Wave of Organic Foods
by Zacks Equity Research
Increasing shift to organic production techniques to satisfy changing consumer preference should bolster demand for agri-based products.
Limoneira (LMNR) Q3 Earnings Miss Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of -5.66% and 6.03%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
Limoneira (LMNR) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Limoneira (LMNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brown-Forman Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Brown-Forman (BF.B) touches a 52-week high on the back of its robust strategies, including growth and expansion plans, solid brand portfolio along with an impressive surprise trend.
Dean Foods (DF) Stock Gains on Q1 Earnings & Sales Beat
by Zacks Equity Research
Dean Foods (DF) began 2018 on a solid note as first-quarter results outpaced the estimates. Further, its enterprise-wide productivity program to boost operational excellence is impressive.
Clorox (CLX) Q3 Earnings Beats Estimates, Trims '18 EPS View
by Zacks Equity Research
Clorox (CLX) delivered solid third-quarter fiscal 2018 results driven by its 2020 Strategy and other initiatives. However, management cut down its earnings guidance for the fiscal year.
Archer Daniels (ADM) Beats on Q1 Earnings & Sales, Up Y/Y
by Zacks Equity Research
Archer Daniels' (ADM) impressive first-quarter 2018 results can be attributed to its robust strategic initiatives. With this, the company breaks its more than three-year long trend of sales misses.
Archer Daniels' Cost-Savings Plan on Track: Should You Buy?
by Zacks Equity Research
Archer Daniels (ADM) consistently gains from strategic initiatives like cost-savings efforts, meaningful acquisitions, organic growth projects undertaken and efficient portfolio management.
Archer Daniels' Realigned Business Units Shows Renewed Focus
by Zacks Equity Research
Archer Daniels (ADM) announced the realignment of the business segments into four units to boost growth across business portfolio.
Archer Daniels' Cost Savings on Track, Soft Sales a Concern
by Zacks Equity Research
Archer-Daniels-Midland (ADM) focuses on strengthening its business through increased cost savings. However, its top line has been lagging the estimates for over three years now.
Company News For Sep 13, 2017
by Zacks Equity Research
Companies in the news are: TEVA,WDC,AMZN,LMNR
Cosan (CZZ) Posts Profit in Q2, Maintains '17 Guidance
by Zacks Equity Research
Cosan Limited (CZZ) second-quarter 2017 results improved on a year-over-year basis, with adjusted net income of R$55.8 million comfortably surpassing a net loss of R$91.3 million in the year-ago quarter.
Volumes Dent Dean Foods (DF) Q2 Earnings & View, Stock Slumps
by Zacks Equity Research
Dean Foods Company's (DF) 2Q17 was hurt by a tough retail scenario. Further, volumes remained pressured owing to macro factors and stiff competition.
Boston Beer Stock Up 11.1% Since Q2 Earnings: Here's Why
by Zacks Equity Research
Shares of Boston Beer Company, Inc. (SAM) rose over 11% after it posted solid second-quarter 2017 results on Jul 27. Also, it raised the lower-end of previous earnings guidance range.
Tyson Foods Restructures Organization to Boost Efficiency
by Zacks Equity Research
Tyson Foods, Inc. (TSN) is streamlining the organizational structure in order to maximize growth and also boost the segments' efficiency by taking quick and convenient decisions.
Clorox (CLX) Q4 Earnings & Sales Beat the Zacks Consensus
by Zacks Equity Research
The Clorox Company (CLX) released 4Q17 results, wherein earnings benefited from strong sales and cost savings. Sales were backed by favorable volumes and pricing.
Archer Daniels (ADM) Q2 Earnings Beat, Revenues Miss Again
by Zacks Equity Research
Archer Daniels Midland Company (ADM) posted 2Q17 results. The bottom line gained from focus on strategic initiatives while sales continued with its dismal surprise trend of over three years.